Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area.[J Forensic Sci. 2007]

Shields LB, Hunsaker Iii JC, Corey TS, Ward MK, Stewart D

J Forensic Sci. 2007 Nov; 52(6):1389-95.

Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.[Chem Res Toxicol. 1996]

Iribarne C, Berthou F, Baird S, Dréano Y, Picart D, Bail JP, Beaune P, Ménez JF

Chem Res Toxicol. 1996 Mar; 9(2):365-73.
The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone.[Drug Metab Dispos. 1997]

Moody DE, Alburges ME, Parker RJ, Collins JM, Strong JM

Drug Metab Dispos. 1997 Dec; 25(12):1347-53.
Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401.[J Acquir Immune Defic Syndr. 2001]

Gerber JG, Rosenkranz S, Segal Y, Aberg J, D'Amico R, Mildvan D, Gulick R, Hughes V, Flexner C, Aweeka F, Hsu A, Gal J, ACTG 401 Study Team.

J Acquir Immune Defic Syndr. 2001 Jun 1; 27(2):153-60.
Novel metabolites of buprenorphine detected in human liver microsomes and human urine.[Drug Metab Dispos. 2006]

Chang Y, Moody DE, McCance-Katz EF

Drug Metab Dispos. 2006 Mar; 34(3):440-8.

Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity.[Drug Alcohol Depend. 2009]

Kharasch ED, Walker A, Whittington D, Hoffer C, Bedynek PS

Drug Alcohol Depend. 2009 May 1; 101(3):158-68.
Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavir/indinavir.[Anesthesiology. 2009]

Kharasch ED, Hoffer C, Whittington D, Walker A, Bedynek PS

Anesthesiology. 2009 Mar; 110(3):660-72.
Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).[J Acquir Immune Defic Syndr Hum Retrovirol. 1998]

McCance-Katz EF, Rainey PM, Jatlow P, Friedland G

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):435-43.

Cocaethylene: pharmacology, physiology and behavioral effects in humans.[J Pharmacol Exp Ther. 1995]

McCance EF, Price LH, Kosten TR, Jatlow PI

J Pharmacol Exp Ther. 1995 Jul; 274(1):215-23.
Interaction of methadone with didanosine and stavudine.[J Acquir Immune Defic Syndr. 2000]

Rainey PM, Friedland G, McCance-Katz EF, Andrews L, Mitchell SM, Charles C, Jatlow P

J Acquir Immune Defic Syndr. 2000 Jul 1; 24(3):241-8.

Injecting misuse of buprenorphine among French drug users.[Addiction. 2001]

Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti JP

Addiction. 2001 Feb; 96(2):267-72.
Clinical pharmacology of buprenorphine: ceiling effects at high doses.[Clin Pharmacol Ther. 1994]

Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE

Clin Pharmacol Ther. 1994 May; 55(5):569-80.
Six deaths linked to concomitant use of buprenorphine and benzodiazepines.[Addiction. 1998]

Reynaud M, Petit G, Potard D, Courty P

Addiction. 1998 Sep; 93(9):1385-92.

Review Pharmacologic treatments for heroin and cocaine dependence.[Am J Addict. 2003]

Kleber HD

Am J Addict. 2003; 12(s2):S5-S18.
Review Office-based buprenorphine treatment for opioid-dependent patients.[Harv Rev Psychiatry. 2004]

McCance-Katz EF

Harv Rev Psychiatry. 2004 Nov-Dec; 12(6):321-38.

Review Antiretroviral drugs.[J Clin Pharmacol. 2007]

Warnke D, Barreto J, Temesgen Z

J Clin Pharmacol. 2007 Dec; 47(12):1570-9.
Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection.[J Acquir Immune Defic Syndr (1988). 1992]

Schwartz EL, Brechbühl AB, Kahl P, Miller MA, Selwyn PA, Friedland GH

J Acquir Immune Defic Syndr (1988). 1992; 5(6):619-26.
Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262).[J Acquir Immune Defic Syndr Hum Retrovirol. 1998]

McCance-Katz EF, Rainey PM, Jatlow P, Friedland G

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):435-43.

Effect of opioid dependence pharmacotherapies on zidovudine disposition.[Am J Addict. 2001]

McCance-Katz EF, Rainey PM, Friedland G, Kosten TR, Jatlow P

Am J Addict. 2001 Fall; 10(4):296-307.

Interaction of methadone with didanosine and stavudine.[J Acquir Immune Defic Syndr. 2000]

Rainey PM, Friedland G, McCance-Katz EF, Andrews L, Mitchell SM, Charles C, Jatlow P

J Acquir Immune Defic Syndr. 2000 Jul 1; 24(3):241-8.
Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir.[Am J Addict. 2010]

Baker J, Rainey PM, Moody DE, Morse GD, Ma Q, McCance-Katz EF

Am J Addict. 2010 Jan-Feb; 19(1):17-29.

Review Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.[Adv Exp Med Biol. 1996]

Freimuth WW

Adv Exp Med Biol. 1996; 394():279-89.
Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine.[Am J Addict. 2006]

McCance-Katz EF, Rainey PM, Smith P, Morse GD, Friedland G, Boyarsky B, Gourevitch M, Jatlow P

Am J Addict. 2006 Jan-Feb; 15(1):23-34.
Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir.[AIDS. 2006]

Bruce RD, Altice FL

AIDS. 2006 Mar 21; 20(5):783-4.
Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.[Drug Alcohol Depend. 2007]

McCance-Katz EF, Moody DE, Morse GD, Ma Q, DiFrancesco R, Friedland G, Pade P, Rainey PM

Drug Alcohol Depend. 2007 Dec 1; 91(2-3):269-78.

Pharmacokinetic drug interactions with nevirapine.[J Acquir Immune Defic Syndr. 2003]

Back D, Gibbons S, Khoo S

J Acquir Immune Defic Syndr. 2003 Sep; 34 Suppl 1():S8-14.
Review Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.[Clin Infect Dis. 2005]

McCance-Katz EF

Clin Infect Dis. 2005 Jul 1; 41 Suppl 1():S89-95.
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.[Clin Infect Dis. 2006]

McCance-Katz EF, Moody DE, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Smith P, Ogundele A, Jatlow P, Rainey PM

Clin Infect Dis. 2006 Dec 15; 43 Suppl 4():S224-34.
The metabolism and excretion of buprenorphine in humans.[Drug Metab Dispos. 1984]

Cone EJ, Gorodetzky CW, Yousefnejad D, Buchwald WF, Johnson RE

Drug Metab Dispos. 1984 Sep-Oct; 12(5):577-81.
Review Office-based buprenorphine treatment for opioid-dependent patients.[Harv Rev Psychiatry. 2004]

McCance-Katz EF

Harv Rev Psychiatry. 2004 Nov-Dec; 12(6):321-38.

Rifampin-induced methadone withdrawal.[N Engl J Med. 1976]

Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM

N Engl J Med. 1976 May 13; 294(20):1104-6.
Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users.[Drug Alcohol Depend. 1996]

Brown LS, Sawyer RC, Li R, Cobb MN, Colborn DC, Narang PK

Drug Alcohol Depend. 1996 Dec 2; 43(1-2):71-7.
Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.[Eur J Clin Pharmacol. 2002]

Wen X, Wang JS, Neuvonen PJ, Backman JT

Eur J Clin Pharmacol. 2002 Jan; 57(11):799-804.

Review Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.[Clin Infect Dis. 2000]

Sulkowski MS, Mast EE, Seeff LB, Thomas DL

Clin Infect Dis. 2000 Apr; 30 Suppl 1():S77-84.
Review Hepatitis C virus infection.[N Engl J Med. 2001]

Lauer GM, Walker BD

N Engl J Med. 2001 Jul 5; 345(1):41-52.
Review Side effects of therapy of hepatitis C and their management.[Hepatology. 2002]

Fried MW

Hepatology. 2002 Nov; 36(5 Suppl 1):S237-44.
Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment.[Clin Ther. 2007]

Berk SI, Litwin AH, Arnsten JH, Du E, Soloway I, Gourevitch MN

Clin Ther. 2007 Jan; 29(1):131-8.
The effect of multiple doses of peginterferon alfa-2b on the steady-state pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy.[J Clin Pharmacol. 2007]

Gupta SK, Sellers E, Somoza E, Angles L, Kolz K, Cutler DL

J Clin Pharmacol. 2007 May; 47(5):604-12.

Methadone, ciprofloxacin, and adverse drug reactions.[Lancet. 2000]

Herrlin K, Segerdahl M, Gustafsson LL, Kalso E

Lancet. 2000 Dec 16; 356(9247):2069-70.

Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.[Arch Gen Psychiatry. 1997]

Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE

Arch Gen Psychiatry. 1997 Jan; 54(1):71-80.

A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts.[Arch Gen Psychiatry. 1986]

Kosten TR, Rounsaville BJ, Kleber HD

Arch Gen Psychiatry. 1986 Aug; 43(8):733-8.

In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.[Fundam Clin Pharmacol. 1998]

Iribarne C, Picart D, Dréano Y, Berthou F

Fundam Clin Pharmacol. 1998; 12(2):194-9.
Fluoxetine addition to methadone in addicts: pharmacokinetic aspects.[Ther Drug Monit. 1996]

Bertschy G, Eap CB, Powell K, Baumann P

Ther Drug Monit. 1996 Oct; 18(5):570-2.
Probable metabolic interaction between methadone and fluvoxamine in addict patients.[Ther Drug Monit. 1994]

Bertschy G, Baumann P, Eap CB, Baettig D

Ther Drug Monit. 1994 Feb; 16(1):42-5.
The effect of sertraline on methadone plasma levels in methadone-maintenance patients.[Am J Addict. 2000]

Hamilton SP, Nunes EV, Janal M, Weber L

Am J Addict. 2000 Winter; 9(1):63-9.
Review Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.[Clin Pharmacokinet. 1996]

Baumann P

Clin Pharmacokinet. 1996 Dec; 31(6):444-69.
Serotonin syndrome: a complex but easily avoidable condition.[Gen Hosp Psychiatry. 2008]

Dvir Y, Smallwood P

Gen Hosp Psychiatry. 2008 May-Jun; 30(3):284-7.

Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: a study using the U.K. and Germany Mediplus databases.[Pain Pract. 2008]

Gore M, Sadosky A, Leslie D, Sheehan AH

Pain Pract. 2008 Jul-Aug; 8(4):253-62.
An in vitro approach to potential methadone metabolic-inhibition interactions.[Eur J Clin Pharmacol. 2007]

Bomsien S, Skopp G

Eur J Clin Pharmacol. 2007 Sep; 63(9):821-7.

Review Clinical drugs that interact with St. John's wort and implication in drug development.[Curr Pharm Des. 2008]

Di YM, Li CG, Xue CC, Zhou SF

Curr Pharm Des. 2008; 14(17):1723-42.

Increased (R)-methadone plasma concentrations by quetiapine in cytochrome P450s and ABCB1 genotyped patients.[J Clin Psychopharmacol. 2007]

Uehlinger C, Crettol S, Chassot P, Brocard M, Koeb L, Brawand-Amey M, Eap CB

J Clin Psychopharmacol. 2007 Jun; 27(3):273-8.

Heroin overdose is often the truer description.[Addiction. 1999]

Tagliaro F, De Battisti Z

Addiction. 1999 Jul; 94(7):973-4.
Diazepam and methadone blood levels following concurrent administration of diazepam and methadone.[Drug Alcohol Depend. 1986]

Preston KL, Griffiths RR, Cone EJ, Darwin WD, Gorodetzky CW

Drug Alcohol Depend. 1986 Oct; 18(2):195-202.
Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.[Drug Alcohol Depend. 2007]

Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J

Drug Alcohol Depend. 2007 Dec 1; 91(2-3):187-94.
Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.[J Clin Psychopharmacol. 2006]

Lintzeris N, Mitchell TB, Bond A, Nestor L, Strang J

J Clin Psychopharmacol. 2006 Jun; 26(3):274-83.
Detection of alprazolam in three cases of methadone/benzodiazepine overdose.[J Forensic Sci. 1997]

Rogers WO, Hall MA, Brissie RM, Robinson CA

J Forensic Sci. 1997 Jan; 42(1):155-6.
Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.[Addiction. 2007]

Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D

Addiction. 2007 Apr; 102(4):616-22.
Review Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences.[Toxicol Rev. 2006]

Mégarbane B, Hreiche R, Pirnay S, Marie N, Baud FJ

Toxicol Rev. 2006; 25(2):79-85.

Review Clinically relevant drug interactions with antiepileptic drugs.[Br J Clin Pharmacol. 2006]

Perucca E

Br J Clin Pharmacol. 2006 Mar; 61(3):246-55.

Review Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view.[Curr Drug Metab. 2003]

Sharma A, Hamelin BA

Curr Drug Metab. 2003 Apr; 4(2):105-29.

Review Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.[Clin Pharmacokinet. 1995]

Ereshefsky L, Riesenman C, Lam YW

Clin Pharmacokinet. 1995; 29 Suppl 1():10-8; discussion 18-9.
Increase in desipramine serum levels associated with methadone treatment.[Am J Psychiatry. 1989]

Maany I, Dhopesh V, Arndt IO, Burke W, Woody G, O'Brien CP

Am J Psychiatry. 1989 Dec; 146(12):1611-3.
Dextromethorphan-induced delirium and possible methadone interaction.[Am J Geriatr Pharmacother. 2005]

Lotrich FE, Rosen J, Pollock BG

Am J Geriatr Pharmacother. 2005 Mar; 3(1):17-20.

Effect of other drugs and chemicals on the degradation of aspirin in vitro: possible extrapolation to in vivo metabolism of aspirin.[Eur J Drug Metab Pharmacokinet. 1979]

Gupta JD, Gruca M, Ablett W

Eur J Drug Metab Pharmacokinet. 1979; 4(2):103-8.

Effect of cocaine use on buprenorphine pharmacokinetics in humans.[Am J Addict. 2010]

McCance-Katz EF, Rainey PM, Moody DE

Am J Addict. 2010 Jan-Feb; 19(1):38-46.
Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine.[Hepatology. 1996]

Pellinen P, Stenbäck F, Kojo A, Honkakoski P, Gelboin HV, Pasanen M

Hepatology. 1996 Mar; 23(3):515-23.
Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms.[Life Sci. 1995]

Madden JA, Konkol RJ, Keller PA, Alvarez TA

Life Sci. 1995; 56(9):679-86.
Effect of cocaine use on methadone pharmacokinetics in humans.[Am J Addict. 2010]

McCance-Katz EF, Jatlow P, Rainey PM

Am J Addict. 2010 Jan-Feb; 19(1):47-52.

Patterns of cocaine use and HIV infection among injection drug users in a methadone clinic.[J Subst Abuse. 1994]

Nemoto T

J Subst Abuse. 1994; 6(2):169-78.
Effects of buprenorphine on the self-administration of cocaine by humans.[Behav Pharmacol. 1994]

Foltin RW, Fischman MW

Behav Pharmacol. 1994 Feb; 5(1):79-89.

Review Opioid interactions with alcohol.[Adv Alcohol Subst Abuse. 1984]

Kreek MJ

Adv Alcohol Subst Abuse. 1984 Summer; 3(4):35-46.
Metabolic interactions between opiates and alcohol.[Ann N Y Acad Sci. 1981]

Kreek MJ

Ann N Y Acad Sci. 1981; 362():36-49.

QTc interval screening in methadone treatment.[Ann Intern Med. 2009]

Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC

Ann Intern Med. 2009 Mar 17; 150(6):387-95.
Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.[Pharmacotherapy. 2003]

Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS

Pharmacotherapy. 2003 Jun; 23(6):802-5.
Methadone-induced Torsade de pointes after stopping lopinavir-ritonavir.[Eur J Clin Microbiol Infect Dis. 2007]

Lüthi B, Huttner A, Speck RF, Mueller NJ

Eur J Clin Microbiol Infect Dis. 2007 May; 26(5):367-9.
Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients.[Ann Pharmacother. 2006]

Baker JR, Best AM, Pade PA, McCance-Katz EF

Ann Pharmacother. 2006 Mar; 40(3):392-6.

Save items

Similar articles in PubMed

Cited by other articles in PMC

Links

Recent Activity